Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.18 (
glutathione S-transferase
)
22,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The full-length cDNA clone of a novel
GRP78-binding protein
(
GBP
) was isolated from rat brain using PCR-selected cDNA subtraction.
GBP
was predominantly expressed in neuronal cells among various brain tissues.
GBP
mRNA was already detected in the E12 brain and then gradually increased to reach a peak within P0-2 weeks after birth.
GBP
expression in the brain decreased age-dependently to approximately 30% of the postnatal level at 12 months.
GBP
encoded 1021 amino acids and was predicted to have two transmembrane regions and glutamic acid- and proline-rich regions. Because the sequence of
GBP
offered few clues to the possible function, we performed a
GST
-tagged
GBP
pull-down assay in PC12 lysates and identified GRP78, one of the heat shock proteins, as a counterpart. Observation of COS7 cells expressing green fluorescent protein- or Myc-tagged
GBP
showed that
GBP
was localized in the endoplasmic reticulum-Golgi domain where BODIPY 558/568 (4,4-difluro-5-(2-thienyl)-4-bora-3alpha,4alpha-diaza-S-indacene)-labeled brefeldin A accumulated. To investigate a biological role for
GBP
, we established Neuro2a cells stably expressing Myc-tagged
GBP
. Overexpression of
GBP
did not affect cell growth or morphological features but attenuated the time-dependent decrease in cell viability caused by serum deprivation compared with control cells. After 48 h of serum starvation, Neuro2a cells overexpressing
GBP
were resistant to the cell death induced by serum withdrawal. These results suggest that
GBP
would have a relevant functional role in embryonic and postnatal development of the brain.
...
PMID:Cloning and characterization of a novel GRP78-binding protein in the rat brain. 1251 90